Latest Senile plaques Stories
Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing
New research has opened the door to other possible methods for diagnosing Alzheimer's disease, including a blood test, sense of smell exam and determining protein build-up in the eyes.
BERLIN and BOSTON, March 20, 2014 /PRNewswire/ -- Piramal Imaging today announced that the U.S. Food and Drug Administration (FDA) has approved Neuraceq(TM).
Alzheimer's disease has long been marked by progress -- but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age
Two rare mutations in the human gene that lead to the most common, late-onset variant of Alzheimer's have been identified by Chair Member of the Cure Alzheimer's Disease Research Consortium,
Researchers have created a new class of imaging agents that could allow them to view the biological processes that occur in the brain during the development and progression of Alzheimer’s disease.
In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid.
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease.
Mount Sinai researchers find reduction in brain plaques in mice after treatment with drugs currently prescribed for other indications. New York, NY (PRWEB) June
According to a group researchers, tests of the anti-cancer drug bexarotene failed to stop the formation of the amyloid brain plaques that are associated with Alzheimer’s disease, conflicting with the results of an identical 2012 study.
- Withering but not falling off, as a blossom that persists on a twig after flowering.